Evecxia Doses First Patient in Phase 1b Brain Target Engagement Study of Serotonin Synthesis Amplification Therapy - Business Wire

Submitted by Anonymous (not verified) on Mon, 02/09/2026 - 13:00

Evecxia Doses First Patient in Phase 1b Brain Target Engagement Study of Serotonin Synthesis Amplification Therapy  Business Wire